Thalidomide News and Research

RSS
Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Thalidomide improves remission in myeloma

Thalidomide improves remission in myeloma

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Thalomid gives hope for blood cancer sufferers

Thalomid gives hope for blood cancer sufferers

HOXA1 is a gene that's been looking for a disorder for a long time

HOXA1 is a gene that's been looking for a disorder for a long time

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Activist groups hinder important clinical trials of HIV medication

Activist groups hinder important clinical trials of HIV medication

Thalidomide may be a potent anti-cancer treatment

Thalidomide may be a potent anti-cancer treatment

Monitoring program has successfully identified a large number of previously unknown, serious and often-fatal drug reactions

Monitoring program has successfully identified a large number of previously unknown, serious and often-fatal drug reactions

Fifteen-year hunt uncovers gene behind pseudothalidomide syndrome

Fifteen-year hunt uncovers gene behind pseudothalidomide syndrome

Thalidomide - new treatment for cancer

Thalidomide - new treatment for cancer

Thalidomide may have a new lease of life as a cancer treatment

Thalidomide may have a new lease of life as a cancer treatment

Dramatic changes in the way the FDA address patient safety are needed

Dramatic changes in the way the FDA address patient safety are needed

Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients

Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

Thalidomide shows promise in fighting myeloma

Thalidomide shows promise in fighting myeloma

Eight out of ten women take some form of therapeutic drugs during pregnancy

Eight out of ten women take some form of therapeutic drugs during pregnancy

The next generation of single-enantiomer catalysts

The next generation of single-enantiomer catalysts

Revised cholesterol-lowering guidelines constitute a major risk to public health

Revised cholesterol-lowering guidelines constitute a major risk to public health

Thalidomide's role in fighting blood disorders, such as multiple myeloma

Thalidomide's role in fighting blood disorders, such as multiple myeloma